Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 998 of 5804
-
Shorter TB regimens could simplify treatment
Disease control Not yet recruitingRIFA-REAL is a prospective observational longitudinal study evaluating the safety, feasibility, and effectiveness of rifapentine-based shorter treatment regimens for drug-susceptible tuberculosis (DS-TB) and tuberculosis infection (TBI) under routine programmatic conditions in Ka…
Sponsor: Public Union "Kazakhstan Association of Phthisiopulmonologists" • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New combo without chemotherapy aims to shrink rectal tumors before surgery
Disease control Not yet recruitingThis is a small Phase II study testing whether targeted internal radiation treatment (HDREBT) followed by two doses of the immunotherapy drug Nivolumab is safe, practical, and potentially effective before patients undergo surgery (TME) to remove rectal cancer.
Phase: PHASE2 • Sponsor: Dr. Te Vuong • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Can peer support keep homeless veterans out of the ER?
Disease control Not yet recruitingHomelessness is a national crisis in the United States, particularly in the veteran population. Due to multiple chronic conditions, homeless individuals frequently become hospitalized or are treated in emergency departments. Care engagement can mitigate this risk. Interventions g…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Remote exercise program aims to boost chemo completion in cancer patients
Symptom relief Not yet recruitingThis study will evaluate whether a remotely delivered exercise program can improve chemotherapy tolerability in patients with gastrointestinal or lung cancer receiving chemotherapy. In this decentralized, digital randomized clinical trial, up to 120 adults with gastrointestinal …
Phase: NA • Sponsor: AdventHealth Translational Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Can a daily supplement help the body fight off HPV?
Disease control Not yet recruitingThis interventional, single-center, open-label randomized clinical study evaluates the efficacy of an oral dietary supplement (Pervistop®) in women with persistent Human Papillomavirus (HPV) infection. The supplement is a combination of four natural molecules: Epigallocatechin ga…
Phase: NA • Sponsor: IRCCS San Raffaele • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug SKB571 aims to shrink GI tumors in early trial
Disease control Not yet recruitingThis is an open-label, multicenter, phase II study. The purpose of this study is to evaluate the safety, tolerability and preliminary anti-tumor activity of SKB571 in participants with gastrointestinal tumors.
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Electric shocks boost drug to shrink blood vessel tangles
Disease control Not yet recruitingIn biomedical applications, electroporation is used not only for cancer treatment but also for vaccinations, treatment of cardiac arrhythmias and, more recently, for the treatment of vascular malformations. Bleomycin is a frequently used sclerosing agent in the treatment of vario…
Phase: PHASE2 • Sponsor: Institute of Oncology Ljubljana • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New study tracks Real-World success of breast cancer drug in GCC
Knowledge-focused Not yet recruitingBEYOND study is designed to generate the first real-world data from GCC countries on the patient characteristics, treatment patterns, survival outcomes, and safety of T-DXd in patients with HRpositive,HER2-low or HER2-ultralow mBC previously treated with ET. The evidence generate…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
New MS drug trial uses Super-Powered MRI to see inside the brain
Disease control Not yet recruitingThe study is an investigator-run, study following participants for 2 years with twice-daily remibrutinib. MRI is the main endpoint. Safety, tolerability, and efficacy are secondary endpoints. Approximately 20 participants with relapsing or progressive forms of MS will be recruite…
Phase: PHASE2 • Sponsor: Moein Amin • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug duo aims to tackle stubborn heart risk factor
Disease control Recruiting nowResearchers designed a trial medicine called MK-7262 to lower levels of Lp(a) in the blood. Researchers want to learn about giving MK-7262 with another trial medicine called enlicitide (also known as MK-0616 or enlicitide decanoate). Enlicitide is in a group of medicines that low…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Engineered immune cells take on kidney cancer in first human test
Disease control Recruiting nowThis is a single-arm, open-label, dose-escalating Phase 1 clinical study. It aims to evaluate the safety, tolerability and pharmacokinetic(PK) profiles of the investigational agent, and preliminarily assess its efficacy in subjects with advanced/metastatic renal cell carcinoma, a…
Phase: PHASE1 • Sponsor: Hrain Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat tumors
Disease control Not yet recruitingFor Safety introduction phase,this study is to evaluate the safety and tolerability of LM-168 in combination with other anti-tumor treatment regimens in participants of advanced solid tumor trials, determine the maximum tolerated dose (MTD), and explore the recommended phase II d…
Phase: PHASE2 • Sponsor: LaNova Medicines Limited • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Sticker on the skin could replace scans for shunt checks
Diagnosis Not yet recruitingHydrocephalus is commonly treated with a cerebrospinal fluid (CSF) shunt, a device that drains excess fluid from the brain. However, shunts can stop working over time, and determining whether fluid is flowing through a shunt can be difficult. Current diagnostic methods may requir…
Phase: NA • Sponsor: Rhaeos, Inc. • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Can diet boost immunotherapy? study tests High-Fiber and fasting in melanoma
Knowledge-focused Not yet recruitingThe treatment of melanoma has improved significantly in recent years. A modern form of cancer treatment known as immunotherapy with checkpoint inhibitors plays a key role in this. These drugs help the immune system better recognize and fight cancer cells. Nevertheless, it remains…
Phase: NA • Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
AI coach for parents of autistic kids: could a virtual simulation improve Real-Life communication?
Symptom relief Not yet recruitingThis randomized controlled trial evaluates an AI-based parental simulation designed to support reflective parenting, emotional regulation, and parent-child communication among parents of autistic children aged 3 to 12 years. A total of 140 parents will be recruited through an ext…
Phase: NA • Sponsor: University of Haifa • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New dosing strategy could mean fewer eye injections for Diabetes-Related vision loss
Disease control Not yet recruitingThe goal of this clinical trial is to understand whether Zhuochuming® (Aflibercept Intravitreal Injection) using a 3 loading doses followed by a treat-and-extend regimen (3+T\&E) can treat patients with diabetic macular edema (DME) who have not received prior treatment. It will a…
Phase: PHASE4 • Sponsor: The Third Peoples Hospital of Dalian • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Stomach cancer trial combines chemo and quick radiation to boost remission
Disease control Not yet recruitingStandard treatment for patients with early stage gastric cancer consists of perioperative chemotherapy and surgical resection. If radiation therapy is administered in the adjuvant setting, the radiated area is often large and associated with significant toxicity. In this study, …
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug aims to shield cancer patients from chemo side effects
Disease control Recruiting nowThe goal of this clinical trial is to compare the efficacy and safety of trilaciclib versus placebo in subjects with limited stage small cell lung cancer. The main question it aims to answer is: Does trilaciclib have a myeloprotective effect in subject with limited stage small c…
Phase: PHASE3 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New Parkinson's pill aims to cut 'OFF' time and ease daily struggles
Symptom relief Not yet recruitingThis trial will evaluate the effects of Lu AF28996 in adults with Parkinson's disease (PD) experiencing motor fluctuations despite optimized non-invasive symptomatic treatment. These are individuals with PD who take medications to control movement symptoms, such as slowness, stif…
Phase: PHASE2 • Sponsor: H. Lundbeck A/S • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New drug aims to slow kidney damage in rare alport syndrome
Disease control Recruiting nowThis is a randomized, double-Blind, placebo-controlled study to evaluate the efficacy and safety of exaluren in Alport Syndrome patients with nonsense mutations in COL4A3/4/5 genes. Targeted 24 patients aged 12 and older will be enrolled in the trial. The study will be comprise…
Phase: PHASE2 • Sponsor: Eloxx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC